CERO THERAPEUTICS HOLDINGS, INC. Effective Income Tax Rate Reconciliation, Tax Credit, Amount
CERO THERAPEUTICS HOLDINGS, INC. (CERO) reported Effective Income Tax Rate Reconciliation, Tax Credit, Amount of $62.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxCredits · last filed 2026-04-15
- CERO THERAPEUTICS HOLDINGS, INC. effective income tax rate reconciliation, tax credit, amount for fiscal 2025 was $62.00K, a 84.80% decline from fiscal 2024.
- CERO THERAPEUTICS HOLDINGS, INC. effective income tax rate reconciliation, tax credit, amount for fiscal 2024 was $408.00K, a 138.60% increase from fiscal 2023.
- CERO THERAPEUTICS HOLDINGS, INC. effective income tax rate reconciliation, tax credit, amount for fiscal 2023 was $171.00K.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Amount 11 month | Effective Income Tax Rate Reconciliation, Tax Credit, Amount 12 month |
|---|---|---|
| 2025-12-31 | $62.00K 10-K · filed 2026-04-15 | |
| 2024-12-31 | $408.00K 10-K · filed 2026-04-15 | $408.00K 10-K · filed 2025-04-15 |
| 2023-12-31 | $171.00K 10-K · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |